Abstract
In the suppression of the growth of a mouse lymphoma 6C3HED by antibody, the effectiveness of antibody in suppressing growing or established tumor cells and comparable number of freshly injected tumor cells is quantitatively similar. The effectiveness of antibody diminishes markedly when the number of tumor cells per mouse reaches the level of 10(6) due to the development of a macrophage shortage. At the 10(5) tumor cells level, antibody-mediated suppression takes place in an optimal manner and between 10(5) and 10(4) tumor cell numbers, the amount of antibody required to suppress 50% of the tumor cells is directly proportional to the number of tumor cells suppressed.
Full Text
The Full Text of this article is available as a PDF (628.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fauve R. M., Hevin B., Jacob H., Gaillard J. A., Jacob F. Antiinflammatory effects of murine malignant cells. Proc Natl Acad Sci U S A. 1974 Oct;71(10):4052–4056. doi: 10.1073/pnas.71.10.4052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fuller T. C., Winn H. J. Immunochemical and biologic characterization of alloantibody active in immunologic enhancement. Transplant Proc. 1973 Mar;5(1):585–587. [PubMed] [Google Scholar]
- Irvin G. L., 3rd, Eustace J. C., Fahey J. L. Inhancement activity of mouse immunoglobulin classes. J Immunol. 1967 Dec;99(6):1085–1091. [PubMed] [Google Scholar]
- Lamon E. W., Whitten H. D., Lidin B., Fudenberg H. H. IgM-induced tumor cell cytotoxicity mediated by normal thymocytes. J Exp Med. 1975 Aug 1;142(2):542–547. doi: 10.1084/jem.142.2.542. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Motta R. Passive immunotherapy of leukemia and other cancer. Adv Cancer Res. 1971;14:161–179. doi: 10.1016/s0065-230x(08)60520-5. [DOI] [PubMed] [Google Scholar]
- North R. J., Kirstein D. P., Tuttle R. L. Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection. J Exp Med. 1976 Mar 1;143(3):559–573. doi: 10.1084/jem.143.3.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perlmann P., Holm G. Cytotoxic effects of lymphoid cells in vitro. Adv Immunol. 1969;11:117–193. doi: 10.1016/s0065-2776(08)60479-4. [DOI] [PubMed] [Google Scholar]
- Rubinstein P., Decary F., Streun E. W. Quantitative studies on tumor enhancement in mice. I. Enhancement of sarcoma I induced by IgM, IgG1, and IgG2. J Exp Med. 1974 Aug 1;140(2):591–596. doi: 10.1084/jem.140.2.591. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shin H. S., Hayden M., Langley S., Kaliss N., Smith M. R. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts. J Immunol. 1975 Apr;114(4):1255–1263. [PubMed] [Google Scholar]
- Shin H. S., Hayden M., Langley S., Kaliss N., Smith M. R. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts. J Immunol. 1975 Apr;114(4):1255–1263. [PubMed] [Google Scholar]
- Shin H. S., Kaliss N., Borenstein D. Antibody-mediated suppression of grafted lymphoma cells. I. Participation of a host factor(s) other than complement. Proc Soc Exp Biol Med. 1972 Feb;139(2):684–689. doi: 10.3181/00379727-139-36216. [DOI] [PubMed] [Google Scholar]
- Shortman K., Williams N., Jackson H., Russell P., Byrt P., Diener E. The separation of different cell classes from lymphoid organs. IV. The separation of lymphocytes from phagocytes on glass bead columns, and its effect on subpopulations of lymphocytes and antibody-forming cells. J Cell Biol. 1971 Mar;48(3):566–579. doi: 10.1083/jcb.48.3.566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Snyderman R., Pike M. C. An inhibitor of macrophage chemotaxis produced by neoplasms. Science. 1976 Apr 23;192(4237):370–372. doi: 10.1126/science.946556. [DOI] [PubMed] [Google Scholar]
- WINN H. J. Immune mechanisms in homotransplantation. I. The role of serum antibody and complement in the neutralization of lymphoma cells. J Immunol. 1960 May;84:530–538. [PubMed] [Google Scholar]
- Zighelboim J., Bonavida B., Fahey J. L. Antibody-mediated in vivo suppression of EL4 leukemia in a syngeneic host. J Natl Cancer Inst. 1974 Mar;52(3):879–881. doi: 10.1093/jnci/52.3.879. [DOI] [PubMed] [Google Scholar]